Erratum: Cancer outcomes and all-cause mortality in adults allocated to metformin: Systematic review and collaborative meta-analysis of randomised clinical trials (Diabetologia DOI: 10.1007/s00125-012-2653-7)

Diabetologia

Volumn 55, Issue 12, 2012, Pages 3399-3400

  Stevens, R J ^a   Ali, R ^b   Bankhead, C R ^a   Bethel, M A ^b   Cairns, B J ^b   Camisasca, R P ^c   Crowe, F L ^b   Farmer, A J ^a   Harrison, S ^a   Hirst, J A ^a   Home, P ^d   Kahn, S E ^e   McLellan, J H ^a   Perera, R ^a   Pluddemann A ^a   Ramachandran, A ^f   Roberts, N W ^a   Rose, P W ^a   Schweizer, A ^g   Viberti, G ^h   Holman, R R ^b   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Takeda Pharmaceutical Company   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f Dr A Ramachandran's Diabetes Hospitals   (India)

^g NOVARTIS PHARMA AG   (Switzerland)

^h KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85028118271     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2740-9     Document Type: Erratum

References (0)